| Patent | Date |
|---|
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb
App 20220072005 - VALCARCE LOPEZ; Maria Carmen ; et al. | 2022-03-10 |
Use of a PPAR-.delta. agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
Grant 11,096,946 - Valcarce Lopez , et al. August 24, 2 | 2021-08-24 |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
Grant 10,751,311 - Ohlstein , et al. A | 2020-08-25 |
Pharmaceutical Compositions And The Treatment Of Overactive Bladder
App 20200246292 - Kind Code | 2020-08-06 |
Pharmaceutical compositions and the treatment of overactive bladder
Grant 10,668,034 - Caltabiano , et al. | 2020-06-02 |
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb
App 20200046717 - VALCARCE LOPEZ; Maria Carmen ; et al. | 2020-02-13 |
Pharmaceutical Compositions And The Treatment Of Overactive Bladder
App 20190365683 - Caltabiano; Stephen ; et al. | 2019-12-05 |
Use of a PPAR-.delta. agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
Grant 10,456,406 - Valcarce Lopez , et al. Oc | 2019-10-29 |
Pharmaceutical compositions and the treatment of overactive bladder
Grant 10,350,182 - Caltabiano , et al. July 16, 2 | 2019-07-16 |
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms
App 20190083434 - OHLSTEIN; Eliot ; et al. | 2019-03-21 |
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms
App 20190083433 - OHLSTEIN; Eliot ; et al. | 2019-03-21 |
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb
App 20180296562 - VALCARCE LOPEZ; Maria Carmen ; et al. | 2018-10-18 |
Pharmaceutical Compositions And The Treatment Of Overactive Bladder
App 20180147169 - CALTABIANO; Stephen ; et al. | 2018-05-31 |
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb
Grant 9,968,613 - Valcarce Lopez , et al. May 15, 2 | 2018-05-15 |
Compositions and methods of using modified release solabegron for lower urinary tract symptoms
Grant 9,956,194 - Ohlstein , et al. May 1, 2 | 2018-05-01 |
Pharmaceutical compositions and the treatment of overactive bladder
Grant 9,907,767 - Caltabiano , et al. March 6, 2 | 2018-03-06 |
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms
App 20170348263 - OHLSTEIN; Eliot ; et al. | 2017-12-07 |
Dosing Regimens For Beta-3 Adrenoceptor Agonists And Anti-muscarinic Agents For The Treatment And Prevention Of Lower Urinary Tract Symptoms And Overactive Bladder
App 20170348288 - OHLSTEIN; Eliot ; et al. | 2017-12-07 |
Pharmaceutical Compositions And The Treatment Of Overactive Bladder
App 20170151199 - CALTABIANO; Stephen ; et al. | 2017-06-01 |
Method Of Using Solabegron
App 20170035716 - OHLSTEIN; Eliot | 2017-02-09 |
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb
App 20170027950 - Valcarce Lopez; Maria Carmen ; et al. | 2017-02-02 |
Pharmaceutical Combination
Grant 9,522,129 - Caltabiano , et al. December 20, 2 | 2016-12-20 |
Use of a PPAR-delta agonist for treating muscle atrophy
Grant 9,487,493 - Valcarce Lopez , et al. November 8, 2 | 2016-11-08 |
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms
App 20160158176 - OHLSTEIN; Eliot ; et al. | 2016-06-09 |
Use Of A Ppar-delta Agonist For Treating Muscle Atrophy
App 20150072985 - Valcarce Lopez; Maria Carmen ; et al. | 2015-03-12 |
Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists
Grant 8,642,661 - Caltabiano , et al. February 4, 2 | 2014-02-04 |
Pharmaceutical Combination
App 20130172277 - Caltabiano; Stephen ; et al. | 2013-07-04 |
Pharmaceutical Combinations
App 20120035118 - Caltabiano; Stephen ; et al. | 2012-02-09 |
| 